Circadian regulation of renal function and potential role in hypertension

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 4, 2013, Pages 439-444

  Bonny, Olivier ^a   Firsov, Dmitri ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Blood pressure; Chronopharmacology; Circadian clock; Kidney; Sodium

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; EPITHELIAL SODIUM CHANNEL; MESSENGER RNA; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK;

ALDOSTERONE BLOOD LEVEL; ARTERIAL PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MOLECULAR CLOCK; NONHUMAN; OSCILLATION; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; SODIUM ABSORPTION; SODIUM URINE LEVEL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SIGNALING PEPTIDES AND PROTEINS; DRUG CHRONOTHERAPY; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; KIDNEY; SIGNAL TRANSDUCTION;

EID: 84879245451     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32836213b8     Document Type: Review

References (45)

1. Smith E. Health and disease as influenced by the daily, seasonal, and other cyclical changes in the human system. London: Walton and Maberly; 1861.
2. Firsov D, Bonny O. Circadian regulation of renal function. Kidney Int 2010; 78:640-645.
3. Firsov D, Tokonami N, Bonny O. Role of the renal circadian timing system in maintaining water and electrolytes homeostasis. Mol Cell Endocrinol 2012; 349:51-55.
4. Maury E, Ramsey KM, Bass J. Circadian rhythms and metabolic syndrome: from experimental genetics tohuman disease. Circ Res 2010; 106:447-462.
5. Kimura G, Dohi Y, Fukuda M. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res 2010; 33:515-520.
6. Manning AK, Hivert MF, Scott RA, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012; 44:659-669.
7. Woon PY, Kaisaki PJ, Braganca J, et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci U S A 2007; 104:14412-14417.
8. Terracciano A, Sanna S, Uda M, et al. Genome-wide association scan for five major dimensions of personality. Mol Psychiatry 2010; 15:647-656.
9. Bass J. Circadian topology of metabolism. Nature 2012; 491:348-356.
10. Zuber AM, Centeno G, Pradervand S, et al. Molecular clock is involved in predictive circadian adjustment of renal function. Proc Natl Acad Sci U S A 2009; 106:16523-16528.
11. Nikolaeva S, Pradervand S, Centeno G, et al. The circadian clock modulates renal sodium handling. J Am Soc Nephrol 2012; 23:1019-1026.
12. Stow LR, Richards J, Cheng KY, et al. The circadian protein period 1 contributes to blood pressure control and coordinately regulates renal sodium transport genes. Hypertension 2012; 59:1151-1156.
13. Salhi A, Centeno G, Firsov D, et al. Circadian expression of H, K-AT Pase type 2 contributes to the stability of plasma K(+) levels. FASEB J 2012; 26:2859-2867.
14. Saifur Rohman M, Emoto N, Nonaka H, et al. Circadian clock genes directly regulate expression of the Na(+)/H(+) exchanger NHE3 in the kidney. Kidney Int 2005; 67:1410-1419.
15. Menet JS, Rodriguez J, Abruzzi KC, et al. Nascent-Seq reveals novel features of mouse circadian transcriptional regulation. Elife 2012; 1:e00011.
16. Koike N, Yoo SH, Huang HC, et al. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science 2012; 338:349-354.
17. Edgar RS, Green EW, Zhao Y, et al. Peroxiredoxins are conserved markers of circadian rhythms. Nature 2012; 485:459-464.
18. Jouffe C, Cretenet G, Symul L, et al. The circadian clock coordinates ribosome biogenesis. PLoS Biol 2013; 11:e1001455.
19. Feigin RD, Klainer AS, Beisel WR. Circadian periodicity of bloof amino-acids in adult men. Nature 1967; 215:512-514.
20. Dallmann R, Viola AU, Tarokh L, et al. The human circadian metabolome. Proc Natl Acad Sci U S A 2012; 109:2625-2629.
21. Eckel-Mahan KL, Patel VR, Mohney RP, et al. Coordination of the transcriptome and metabolome by the circadian clock. Proc Natl Acad SciU S A2012; 109:5541-5546.
22. Bankir L, Bochud M, Maillard M, et al. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension 2008; 51:891-898.
23. Richards J, Gumz ML. Advances in understanding the peripheral circadian clocks. FASEB J 2012; 26:3602-3613.
24. Susa K, Sohara E, Isobe K, et al. WNK-OSR1/SPAK-NCC signal cascade has circadian rhythm dependent on aldosterone. Biochem Biophys Res Commun 2012; 427:743-747.
25. Doi M, Takahashi Y, Komatsu R, et al. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2009; 16:67-74.
26. Gumz ML, Stow LR, Lynch IJ, et al. The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice. J Clin Invest 2009; 119:2423-2434.
27. Gumz ML, Cheng KY, Lynch IJ, et al. Regulation of alphaENaC expression by the circadian clock protein Period 1 in mpkCCD(c14) cells. Biochim Biophys Acta 2010; 1799:622-629.
28. Richards J, Greenlee MM, Jeffers LA, et al. Inhibition of alphaENaC expression and ENaC activity following blockade of the circadian clock-regulatory kinases CK1delta/{varepsilon}. Am J Physiol Renal Physiol 2012; 303: F918-F927.
29. Ralph MR, Menaker M.A mutation of the circadian system in golden hamsters. Science 1988; 241:1225-1227.
30. Martino TA, Oudit GY, Herzenberg AM, et al. Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters. Am J Physiol Regul Integr Comp Physiol 2008; 294:R1675-1683.
31. Wang Q, Maillard M, Schibler U, et al. Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF. Am J Physiol Regul Integr Comp Physiol 2010; 299:R1013-R1019.
32. Elks CE, Perry JR, Sulem P, et al. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet 2010; 42:1077-1085.
33. Huang J, Sabater-Lleal M, Asselbergs FW, et al. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood 2012; 120:4873-4881.
34. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42:105-116.
35. Sanchez-Juan P, Bishop MT, Aulchenko YS, et al. Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk. Neurobiol Aging 2012; 33:1487; e1421-e1488.
36. Jones CR, Campbell SS, Zone SE, et al. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat Med 1999; 5:1062-1065.
37. Toh KL, Jones CR, He Y, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001; 291:1040-1043.
38. Xu Y, Padiath QS, Shapiro RE, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005; 434:640-644.
39. Williams SR, Zies D, Mullegama SV, et al. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet 2012; 90:941-949.
40. Boggild H, Knutsson A. Shift work, risk factors and cardiovascular disease. Scand J Work Environ Health 1999; 25:85-99.
41. Hublin C, Partinen M, Koskenvuo K, et al. Shift-work and cardiovascular disease: a population-based 22-year follow-up study. Eur J Epidemiol 2010; 25:315-323.
42. Jermendy G, Nadas J, Hegyi I, et al. Assessment of cardiometabolic risk among shift workers in Hungary. Health Qual Life Outcomes 2012; 10:18.
43. Esquirol Y, Perret B, Ruidavets JB, et al. Shift work and cardiovascular risk factors: new knowledge from the past decade. Arch Cardiovasc Dis 2011; 104:636-668.
44. Hermida RC, Ayala DE, Mojon A, et al. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol 2011; 22:2313-2321.
45. Zhao P, Xu P, Wan C, et al. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev 2011; CD004184.